(Q34783150)

4 August 2017

1 reference

title

Use of doping agents, particularly anabolic steroids, in sports and society (English)

1 reference

4 August 2017

3

Anders Rane

1 reference

4 August 2017

2

Mats Garle

1 reference

4 August 2017

Folke Sjöqvist

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

371

1 reference

4 August 2017

issue

9627

1 reference

4 August 2017

page(s)

1872-1882

1 reference

4 August 2017

cites work

Misuse of drugs in sport

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Performance-enhancing drugs, fair competition, and Olympic sport

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

From Olympia to Atlanta: a cultural-historical perspective on diet and athletic training

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Hooked on hormones? An anabolic steroid addiction hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Ergogenic aids: a review of basic science, performance, side effects, and status in sports

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Pharmacoepidemiology of anabolic androgenic steroids: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Androgenic anabolic steroid use among male adolescents in Falkenberg

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Therapeutic use exemption

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Attention to Doping Controls Required When Prescribing for Athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Biochemistry, physiology, and complications of blood doping: facts and speculation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Amphetamine sulfate and athletic performance. I. Objective effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Amphetamine, secobarbital, and athletic performance. III. Quantiative effects on judgment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Pseudoephedrine enhances performance in 1500-m runners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Ephedrine use is risky business

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Drugs and sport. Research findings and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Patterns of ephedra and other stimulant use in collegiate hockey athletes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Human growth hormone doping in sport

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic Steroids: Doctors Denounce Them, but Athletes Aren't Listening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Current perspectives on anabolic-androgenic steroid abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic steroids: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Testosterone action on skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Effects of anabolic steroids on the muscle cells of strength-trained athletes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Skeletal muscle morphology in power-lifters with and without anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

The relative safety of ephedra compared with other herbal products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Ephedrine and other stimulants as ergogenic aids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Abuse of supraphysiologic doses of anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

The androgen receptor: a mediator of diverse responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Androgen receptor (AR) coregulators: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Androgens in men--uses and abuses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic Steroid Use and Perceived Effects in Ten Weight-Trained Women Athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Deleterious Effects of Anabolic Steroids on Serum Lipoproteins, Blood Pressure, and Liver Function in Amateur Body Builders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Long-term cardiovascular effects of anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

One- and two-dimensional echocardiography in bodybuilders using anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Increased Premature Mortality of Competitive Powerlifters Suspected to Have Used Anabolic Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Severe cholestasis and jaundice secondary to an esterified testosterone, a non-C17 alkylated anabolic steroid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic steroid use in adolescent athletes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic steroid use by male and female middle school students

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic steroid abuse and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Methyltestosterone with Imipramine in Men: Conversion of Depression to Paranoid Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Affective and psychotic symptoms associated with anabolic steroid use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Neuropsychiatric effects of anabolic steroids in male normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Psychological and serum homovanillic acid changes in men administered androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Oxymethalone and aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Violence Toward Women and Illicit Androgenic-Anabolic Steroid Use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic steroids and violent crime--an epidemiological study at a jail in Stockholm, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Criminality among individuals testing positive for the presence of anabolic androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Effects of steroid hormones on the serotonergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Serotonergic control of androgen-induced dominance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

The anabolic-androgenic steroid nandrolone induces alterations in the density of serotonergic 5HT1B and 5HT2 receptors in the male rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Monoamine metabolites in CSF and suicidal behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic-androgenic steroids as a gateway to opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Cyclist's doping associated with cerebral sinus thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Athletic drug testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Is dehydroepiandrosterone a hormone?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

A functional C-G polymorphism in the CYP7B1 promoter region and its different distribution in Orientals and Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

A novel polymorphism in the 17beta-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in caucasian men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Recombinant erythropoietin and analogues: a challenge for doping control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Anabolic steroid users' attitudes towards physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

Tough new measures are needed to tackle doping in sport, say MPs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960801-6

7 January 2021

10.1016/S0140-6736(08)60801-6

Identifiers

DOI

1 reference

4 August 2017

1 reference